Search This Blog

Thursday, November 7, 2019

Rocket Pharmaceuticals EPS beats by $0.13

Rocket Pharmaceuticals (NASDAQ:RCKT): Q3 GAAP EPS of -$0.38 beats by $0.13.
Cash, cash equivalents and investments of $240.56M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)